Balyasny Asset Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-328,985
| Closed | -$1.98M | – | 1534 |
|
|
2019
Q4 | $1.98M | Buy |
+328,985
| New | +$1.98M | 0.01% | 654 |
|
|
2018
Q3 | – | Sell |
-60,234
| Closed | -$170K | – | 1932 |
|
|
2018
Q2 | $170K | Buy |
60,234
+14,600
| +32% | +$41.2K | ﹤0.01% | 1480 |
|
|
2018
Q1 | $169K | Sell |
45,634
-39,289
| -46% | -$146K | ﹤0.01% | 1594 |
|
|
2017
Q4 | $245K | Buy |
84,923
+66,731
| +367% | +$193K | ﹤0.01% | 1577 |
|
|
2017
Q3 | $82K | Buy |
+18,192
| New | +$82K | ﹤0.01% | 1589 |
|
|
2016
Q3 | – | Sell |
-23,100
| Closed | -$180K | – | 1212 |
|
|
2016
Q2 | $180K | Buy |
+23,100
| New | +$180K | ﹤0.01% | 879 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 568 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 598 |
|